SRF Expands: Capital Expenditure Revised for Fluoropolymer Project

SRF Limited, a leading chemical manufacturer, has announced its consolidated financial results for the second quarter and half year ended 30 September 2025.

During the period, the company entered into a strategic collaboration with The Chemours Company, aimed at advancing opportunities in fluoropolymers and fluoroelastomers, which are expected to drive long-term growth. The Specialty Chemicals Business recorded higher product volumes and benefited from the introduction of new products, while continued improvements in operational efficiency across the Fluorochemicals and Specialty Chemicals segments contributed to stronger margins.

The Performance Films and Foil Business also reported margin expansion in its value-added product portfolio, reaffirming SRF’s leadership in BOPET film exports from India.

The company has revised the capital expenditure for its fluoropolymer project from ₹595 crore to ₹745 crore, with completion of the final phase targeted by December 2026.

News by Rahul Yelligetti.